Bio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare Conference

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a prominent entity in the life science research and clinical diagnostics sectors, has announced that its Chief Executive Officer, Norman Schwartz, and Chief Financial Officer, Roop K. Lakkaraju, will take part in a fireside chat during the 2025 RBC Capital Markets Global Healthcare Conference. This event is scheduled for Wednesday, May 21, 2025, at 1:35 PM Eastern Time (10:35 AM Pacific Time). Interested parties will be able to access a live webcast of the chat, along with a subsequent replay, on the Investor Relations section of Bio-Rad's website.

With a strong operational footprint based in Hercules, California, Bio-Rad employs over 7,500 individuals and reported revenues of approximately $2.6 billion in 2024. The company specializes in the development, manufacturing, and marketing of an extensive range of products tailored for life science research and clinical diagnostics. Its diverse customer base includes universities, research institutions, hospitals, biopharmaceutical firms, and various laboratories focusing on clinical, food safety, and environmental quality testing.

The upcoming fireside chat provides an excellent platform for Bio-Rad's leadership to address key strategic initiatives, research advancements, and market insights, as well as to engage with investors and industry stakeholders regarding the company's future direction and growth prospects.

For more information about Bio-Rad and its innovative, high-quality products that aim to advance scientific discovery and contribute to health improvements, stakeholders and interested parties can visit their official website at bio-rad.com. Key contacts for investor relations and media inquiries include Edward Chung and Anna Gralinska, whose respective contact details are provided in the announcement.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) has announced that its CEO Norman Schwartz and CFO Roop K. Lakkaraju will participate in a fireside chat at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025. This presents a valuable opportunity for investors to gain insights into the company’s strategic direction and performance outlook.

Market participants should pay close attention to the key themes that may emerge during this discussion. Bio-Rad, a leader in life science research and clinical diagnostics, generated approximately $2.6 billion in revenue in 2024 and has a vast customer base ranging from universities to biopharmaceutical companies. This diversity offers resilience and indicates the company’s critical role in advancing health science.

Investors should look for updates on Bio-Rad's innovation pipeline, expansion into new markets, and strategies to enhance its competitive edge, especially in the context of emerging technologies in healthcare. Given the ever-evolving landscape of life sciences, any commitment to R&D or partnerships that leverage advanced diagnostics could signal robust growth potential.

Additionally, management's perspective on the current macroeconomic environment, including any potential impacts from regulatory changes or funding shifts in public health initiatives, is pertinent. These factors could significantly influence operational efficiencies and profitability margins.

The fireside chat will also likely touch on Bio-Rad's financial health, including key performance indicators and guidance for future quarters. Investors should pay close attention to any projected revenue growth and operational challenges that may be highlighted.

In summary, participation in this event offers critical insights and could serve as a barometer for investor sentiment towards Bio-Rad. Monitoring the outcomes of the chat will aid in making informed investment decisions, particularly for those already invested in or considering entering this sector.